Literature DB >> 10654920

Surgical treatment of malignant liver tumours.

R P DeMatteo1, Y Fong, L H Blumgart.   

Abstract

Surgical resection is the mainstay of treatment for malignant liver tumours and offers the only chance of cure. Advances in radiological imaging, surgical technique and peri-operative management have enabled liver resection to be performed safely. Partial hepatectomy is indicated for the treatment of hepatocellular carcinoma and hepatic metastases from colorectal cancer. In addition, it may be utilized for selected patients with liver metastases from other primary tumours. Total hepatectomy with transplantation may be of benefit in some patients with unresectable neuroendocrine metastases or small hepatocellular carcinomas. The role of cryosurgery has not been precisely defined, and it needs to be compared with other palliative therapies such as ethanol injection and hepatic artery embolization.

Entities:  

Mesh:

Year:  1999        PMID: 10654920     DOI: 10.1053/bega.1999.0048

Source DB:  PubMed          Journal:  Baillieres Best Pract Res Clin Gastroenterol


  6 in total

1.  An electrode array that minimizes blood loss for radiofrequency-assisted hepatic resection.

Authors:  D J Schutt; A P O'Rourke; J A Will; J G Webster; D M Mahvi; D Haemmerich
Journal:  Med Eng Phys       Date:  2007-06-27       Impact factor: 2.242

2.  Prognostic impact of intrahepatic lymphatic and microvascular involvement in cases of colorectal liver metastases.

Authors:  Maximilian Bockhorn; Georgios Sotiropoulos; Jan Neuhaus; George Sgourakis; Sien-Yi Sheu; Ernesto Molmenti; Christian Fingas; Tanja Trarbach; Andreja Frilling; Christoph E Broelsch
Journal:  Int J Colorectal Dis       Date:  2009-02-25       Impact factor: 2.571

Review 3.  Hepatocellular carcinoma: is current therapy really altering outcome?

Authors:  P J Johnson
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

Review 4.  Clinical application of bioartificial liver support systems.

Authors:  Maarten Paul van de Kerkhove; Ruurdtje Hoekstra; Robert A F M Chamuleau; Thomas M van Gulik
Journal:  Ann Surg       Date:  2004-08       Impact factor: 12.969

5.  Survival of patients with synchronous and metachronous colorectal liver metastases--is there a difference?

Authors:  Maximilian Bockhorn; Andreja Frilling; Nils R Frühauf; Jan Neuhaus; Ernesto Molmenti; Tanja Trarbach; Massimo Malagó; Hauke Lang; Christoph E Broelsch
Journal:  J Gastrointest Surg       Date:  2008-06-03       Impact factor: 3.452

6.  Preclinical and post-treatment changes in the HCC-associated serum proteome.

Authors:  D G Ward; Y Cheng; G N'Kontchou; T T Thar; N Barget; W Wei; A Martin; M Beaugrand; P J Johnson
Journal:  Br J Cancer       Date:  2006-10-24       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.